AR109364A1 - ANTIVIRAL COMPOUNDS - Google Patents

ANTIVIRAL COMPOUNDS

Info

Publication number
AR109364A1
AR109364A1 ARP170102299A ARP170102299A AR109364A1 AR 109364 A1 AR109364 A1 AR 109364A1 AR P170102299 A ARP170102299 A AR P170102299A AR P170102299 A ARP170102299 A AR P170102299A AR 109364 A1 AR109364 A1 AR 109364A1
Authority
AR
Argentina
Prior art keywords
antiviral compounds
compound
formula
useful
pharmaceutically acceptable
Prior art date
Application number
ARP170102299A
Other languages
Spanish (es)
Inventor
Jennifer R Zhang
Winston C Tse
Dimitrios Stefanidis
Scott D Schroeder
Roland D Saito
Charles William Rowe
John O Link
Steven J Henry
Michael Graupe
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of AR109364A1 publication Critical patent/AR109364A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente descripción se refiere a un compuesto de fórmula (1), (2), (3) y (4), que son útiles en el tratamiento de una infección viral por Retroviridae incluyendo una infección causada por el virus del VIH. Reivindicación 1: Un compuesto de fórmula (1) o una sal farmacéuticamente aceptable del mismo.The present description refers to a compound of formula (1), (2), (3) and (4), which are useful in the treatment of a viral infection by Retroviridae including an infection caused by the HIV virus. Claim 1: A compound of formula (1) or a pharmaceutically acceptable salt thereof.

ARP170102299A 2016-08-19 2017-08-17 ANTIVIRAL COMPOUNDS AR109364A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662377312P 2016-08-19 2016-08-19

Publications (1)

Publication Number Publication Date
AR109364A1 true AR109364A1 (en) 2018-11-21

Family

ID=64499920

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP170102299A AR109364A1 (en) 2016-08-19 2017-08-17 ANTIVIRAL COMPOUNDS
ARP190102131A AR115865A2 (en) 2016-08-19 2019-07-29 THERAPEUTIC COMPOUNDS
ARP190103689A AR117709A2 (en) 2016-08-19 2019-12-16 PHARMACEUTICAL COMPOSITION INCLUDING A SUBSTITUTED 1H-INDAZOLE COMPOUND, SAID COMPOUND AND PARENTERAL FORMULATION OF THE SAME

Family Applications After (2)

Application Number Title Priority Date Filing Date
ARP190102131A AR115865A2 (en) 2016-08-19 2019-07-29 THERAPEUTIC COMPOUNDS
ARP190103689A AR117709A2 (en) 2016-08-19 2019-12-16 PHARMACEUTICAL COMPOSITION INCLUDING A SUBSTITUTED 1H-INDAZOLE COMPOUND, SAID COMPOUND AND PARENTERAL FORMULATION OF THE SAME

Country Status (2)

Country Link
AR (3) AR109364A1 (en)
HR (1) HRP20191601T1 (en)

Also Published As

Publication number Publication date
HRP20191601T1 (en) 2019-11-29
AR117709A2 (en) 2021-08-25
AR115865A2 (en) 2021-03-03

Similar Documents

Publication Publication Date Title
DOP2019000033A (en) THERAPEUTIC COMPOUNDS
CL2018002528A1 (en) Anti viral agents of hepatitis b.
UY37997A (en) ANTIVIRAL AGENTS AGAINST HEPATITIS B
DOP2021000147A (en) THERAPEUTIC COMBINATION COMPRISING LAMIVUDINE
CY1123570T1 (en) HEPATITIS B NUCLEAR PROTEIN MODIFIERS
CU20150096A7 (en) AMIDA COMPOUNDS AND PHARMACEUTICAL COMPOSITION FOR HIV TREATMENT
CO2019000069A2 (en) Antiviral agents against hepatitis b
DOP2019000201A (en) HIV INHIBITING COMPOUNDS
UY37998A (en) ANTIVIRAL AGENTS AGAINST HEPATITIS B
CO2018009382A2 (en) Elimination of hepatitis B virus with antiviral agents
UY37710A (en) INHIBITORS OF THE HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
CL2020000487A1 (en) Antiviral agents against hepatitis b.
CO2017007355A2 (en) Compounds derived from pyrazinecarbozamide and pyrazinecarboxylate for the treatment of hepatitis b virus infection
UY38483A (en) HETEROCYCLES FUNCTIONALIZED AS ANTIVIRAL AGENTS
UY35263A (en) THERAPEUTIC COMPOUNDS
CL2020001146A1 (en) New indole-2-carboxamides substituted with pyrazolopiperidine, of high activity, active against the hepatitis b virus (HBV).
CL2020000886A1 (en) 1-Benzyl-2-imino-4-phenyl-5-oxoimidazolidine derivatives as hiv protease inhibitors.
EA201791872A1 (en) POLYCYCLIC CARBAMOILPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL APPLICATIONS
CR20150611A (en) NOVEDOSAS HETEROARILDIHIDROPIRIMIDINAS UNITED BY BRIDGES IN 6 FOR THE TREATMENT AND PROFILAXIS BY THE VIRUS OF HEPATITIS B
EA201791019A1 (en) POLYCYCLIC CARBAMOILPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL APPLICATIONS
CU24525B1 (en) QUINOLEIN DERIVATIVE TO TREAT AND PREVENT VIRAL INFECTIONS
CL2011002830A1 (en) Compounds derived from haloalkyl heteroaryl benzamides; pharmaceutical composition use of the composition in the treatment of a viral infection, such as hepatitis b and c virus.
AR099632A1 (en) TREATMENT OF A VIRAL INFECTION OF HEPATITIS C, THAT USES A COMBINATION OF COMPOUNDS
UY38383A (en) HETEROCYCLES FUNCTIONALIZED AS ANTIVIRAL AGENTS
EA201490213A1 (en) BENZOFURANE CONNECTIONS FOR THE TREATMENT OF INFECTIONS BY THE HEPATITIS C VIRUS